Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia
- PMID: 39748532
- PMCID: PMC11701467
- DOI: 10.3857/roj.2024.00262
Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia
Abstract
Purpose: Cardiac radioablation is a novel, non-invasive treatment for ventricular tachycardia (VT), involving a single fractional stereotactic ablative body radiotherapy (SABR) session with a prescribed dose of 25 Gy. This complex procedure requires a detailed workflow and stringent dose constraints compared to conventional radiation therapy. This study aims to establish a consistent institutional workflow for single-fraction cardiac VT-SABR, emphasizing robust plan evaluation and quality assurance.
Materials and methods: The study developed a consistent institutional workflow for VT-SABR, including computed tomography (CT) simulation, target volume definition, treatment planning, robust plan evaluation, quality assurance, and image-guided strategy. The workflow was implemented for two patients with cardiac arrhythmia. Accurate target volume definition using planning CT images and electronic anatomical mapping was critical. A four-dimensional (4D) cone-beam CT (CBCT) and breath-hold electrocardiographic gated CT images reliably detected target motion.
Results: The resulting plans exhibited a conformity index greater than 0.7 and a gradient index around G4.0. Dose constraints for the planning target volume (PTV) aimed for 95% or higher PTV dose coverage, with a maximum dose of 200% or lower. However, one case did not meet the PTV dose coverage due to the proximity of the PTV to gastrointestinal organs. Plans adhered to dose constraints for organs at risk near the heart, but meeting constraints for specific cardiac sub-structures was challenging and dependent on PTV location.
Conclusion: The plans demonstrated robustness against respiratory motion and patient positional uncertainty through a robust evaluation function. The 4D and intra-fractional CBCT were effective in verifying target motion and setup stability.
Keywords: Stereotactic ablative radiotherapy; Treatment planning; Ventricular tachycardia.
Conflict of interest statement
No potential conflict of interest concerning this article has been disclosed.
Figures






Similar articles
-
Beyond conventional bounds: Surpassing system limits for stereotactic ablative (SAbR) lung radiotherapy using CBCT-based adaptive planning system.J Appl Clin Med Phys. 2024 Aug;25(8):e14375. doi: 10.1002/acm2.14375. Epub 2024 May 7. J Appl Clin Med Phys. 2024. PMID: 38712917 Free PMC article.
-
Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.Radiother Oncol. 2009 Jun;91(3):314-24. doi: 10.1016/j.radonc.2008.11.018. Epub 2008 Dec 26. Radiother Oncol. 2009. PMID: 19111362 Clinical Trial.
-
Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study.Cureus. 2016 Jul 15;8(7):e694. doi: 10.7759/cureus.694. Cureus. 2016. PMID: 27570715 Free PMC article.
-
Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.J Appl Clin Med Phys. 2015 Jan 8;16(1):5058. doi: 10.1120/jacmp.v16i1.5058. J Appl Clin Med Phys. 2015. PMID: 25679161 Free PMC article.
-
Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia.Heart Rhythm O2. 2021 Sep 20;2(5):511-520. doi: 10.1016/j.hroo.2021.09.001. eCollection 2021 Oct. Heart Rhythm O2. 2021. PMID: 34667967 Free PMC article.
Cited by
-
Establishing protocols and standards for cardiac radioablation: a path toward clinical integration.Radiat Oncol J. 2025 Mar;43(1):4-5. doi: 10.3857/roj.2025.00094. Epub 2025 Mar 18. Radiat Oncol J. 2025. PMID: 40200653 Free PMC article. No abstract available.
References
-
- John RM, Tedrow UB, Koplan BA, et al. Ventricular arrhythmias and sudden cardiac death. Lancet. 2012;380:1520–9. - PubMed
-
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72:e91–220. - PubMed
-
- Shivkumar K. Catheter ablation of ventricular arrhythmias. N Engl J Med. 2019;380:1555–64. - PubMed
-
- Santangeli P, Muser D, Maeda S, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources